Pickup In Korea Biopharma IPO Activity Signals Improving Investor Sentiment

 
• By Jung Won Shin
  
market recovery
South Korea's D&D Pharmatech, ENCell See Strong IPO Demand (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Focus On Asia

More from Business